Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7801 EUR | -2.44% | -1.81% | -61.76% |
14/05 | Biophytis unveils design for obesity study | CF |
14/05 | Biophytis SA Announces the Design of its Phase 2 OBA Clinical Study in Obesity | CI |
Sales 2024 * | - | Sales 2025 * | 4.8M 5.22M 435M | Capitalization | 2.29M 2.49M 207M |
---|---|---|---|---|---|
Net income 2024 * | -19M -20.65M -1.72B | Net income 2025 * | -16M -17.39M -1.45B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.48 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.58% |
1 day | -2.44% | ||
1 week | -1.81% | ||
Current month | -7.13% | ||
1 month | -15.21% | ||
3 months | -54.65% | ||
6 months | -70.00% | ||
Current year | -61.76% |
Date | Price | Change | Volume |
---|---|---|---|
20/24/20 | 0.7801 | -2.44% | 8 319 |
17/24/17 | 0.7996 | +1.04% | 13,125 |
16/24/16 | 0.7914 | -1.08% | 29,813 |
15/24/15 | 0.8 | +2.56% | 44,528 |
14/24/14 | 0.78 | -1.83% | 47,587 |
Real-time Euronext Paris, May 20, 2024 at 03:06 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
-61.76% | 2.49M | |
+9.42% | 115B | |
+11.84% | 106B | |
-2.62% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- ALBPS Stock